Camber Announces Two New Product Launches

Camber Pharmaceuticals, one of the industry’s fastest growing generic pharmaceutical companies is pleased to announce the addition of two new products to its rapidly expanding product line.

The new products are as follows:

Benztropine Mesylate                  Finasteride
– .5mg / 100ct                                – 1mg/ 30ct and 90ct
– 1mg / 100ct and 1000ct
– 2mg / 100ct and 1000ct

Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products from API manufacturing to finished dosage.

Camber’s parent company Hetero Drugs of Hyderabad, India employs over 300 scientists at 9 API facilities and has a global presence in over 100 countries.